Scientists from three national labs have published a comprehensive study that – alongside other recent, complementary studies of coronavirus proteins and genetics – represents the first step toward developing treatments for COVID-19.
Researchers at Stanford and Berkeley Lab’s Molecular Foundry have developed virus-killing molecules called peptoids. The technology could make possible an emerging category of antiviral drugs that could treat everything from herpes and COVID-19 to the common cold.
Berkeley Lab scientist Antoine Snijders helped test a new sanitizing device that appears promising for disinfecting personal protective equipment so that it can be reused longer, which could reduce cost and ease supply chain strain.
Vaccines are turning the tide in the pandemic, but the risk of infection is still present. Instant at-home tests would help us return to normal, but current options aren’t very accurate. A new discovery could help get reliable tests on the market.
Berkeley Lab scientist who leads the development of a widely used data analysis software discusses the role of structural biology in vaccine and antiviral research.
As the COVID-19 pandemic enters its second year, scientists are still working to understand how the new strain of coronavirus evolved, and how it became so much more dangerous than other coronaviruses, which humans have been living alongside for millennia. Virologists and epidemiologists worldwide have speculated for months that a protein called ORF8 likely holds the answer, and a recent study by Berkeley Lab scientists has helped confirm this hypothesis.
A team of biologists who banded together to support COVID-19 science determined the atomic structure of a coronavirus protein thought to help the pathogen evade and dampen response from human immune cells. The structural map – which is now published in the journal PNAS, but has been open-access for the scientific community since August – has laid the groundwork for new antiviral treatments and enabled further investigations into how the newly emerged virus ravages the human body.
To address PPE shortages during the pandemic, scientists at Berkeley Lab and UC Berkeley are developing a rechargeable, reusable, anti-COVID mask design and a 3D-printable silicon-cast mask mold.
Researchers across the world have already amassed tons of info about COVID-19, and learn more every day. Now, Berkeley Lab experts are developing a platform that puts all this valuable knowledge in one place, and leverages machine learning to make new discoveries.
Our biomanufacturing experts are helping accelerate the development of new COVID-19-fighting technologies. Learn how the scientists at the ABPDU are collaborating with biotech companies to scale up and optimize production of coronavirus-targeting antibodies and a highly accurate rapid testing system.